BOSTON, Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...
(RTTNews) - Haemonetics Corp. (HAE) has received FDA clearance for advancements to its NexSys PCS plasma collection system. These include a new plasma collection bowl, featuring a patented design that ...
Haemonetics Corporation HAE has been gaining from strength in the Hospital business. Strong customer end-market demand for NexSys PCS system with Persona technology buoys optimism. A rebound in plasma ...
In recent months, Haemonetics has reported a recovery in its Hospital division, supported by broader adoption of its FDA-approved NexSys PCS system with Persona Technology and the completed transition ...
BOSTON, June 22, 2023 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today announced it ...
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements in this press release may include, without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results